Engagement of NKG2D on Bystander Memory CD8 T Cells Promotes Increased Immunopathology following Infection

English version České info

One of the hallmarks of adaptive immunity is the development of a long-term pathogen specific memory response. While persistent memory T cells certainly impact the immune response during a secondary challenge, their role in unrelated infections is less clear. To address this issue, we utilized lymphocytic choriomeningitis virus (LCMV) and Listeria monocytogenes immune mice to investigate whether bystander memory T cells influence Leishmania major infection. Despite similar parasite burdens, LCMV and Listeria immune mice exhibited a significant increase in leishmanial lesion size compared to mice infected with L. major alone. This increased lesion size was due to a severe inflammatory response, consisting not only of monocytes and neutrophils, but also significantly more CD8 T cells. Many of the CD8 T cells were LCMV specific and expressed gzmB and NKG2D, but unexpectedly expressed very little IFN-γ. Moreover, if CD8 T cells were depleted in LCMV immune mice prior to challenge with L. major, the increase in lesion size was lost. Strikingly, treating with NKG2D blocking antibodies abrogated the increased immunopathology observed in LCMV immune mice, showing that NKG2D engagement on LCMV specific memory CD8 T cells was required for the observed phenotype. These results indicate that bystander memory CD8 T cells can participate in an unrelated immune response and induce immunopathology through an NKG2D dependent mechanism without providing increased protection.

Vyšlo v časopise: Engagement of NKG2D on Bystander Memory CD8 T Cells Promotes Increased Immunopathology following Infection. PLoS Pathog 10(2): e32767. doi:10.1371/journal.ppat.1003970
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003970

Souhrn

Zdroje

1. KohlmeierJE, CookenhamT, RobertsAD, MillerSC, WoodlandDL (2010) Type I interferons regulate cytolytic activity of memory CD8+ T cells in the lung airways during respiratory virus challenge. Immunity 33: 96–105.

2. BergRE, CrossleyE, MurrayS, FormanJ (2003) Memory CD8+ T cells provide innate immune protection against listeria monocytogenes in the absence of cognate antigen. J Exp Med 198: 1583–1593.

3. PolleyR, SanosSL, PrickettS, HaqueA, KayePM (2005) Chronic Leishmania donovani infection promotes bystander CD8+ cell expansion and heterologous immunity. Infect Immun 73: 7996–8001.

4. SoudjaS, RuizA, MarieJ, LauvauG (2012) Inflammatory monocytes activate memory CD8+ T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37: 549–562.

5. ChuT, TyznikA, RoepkeS, BerkleyA, Woodward-DavisA, et al. (2013) Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Rep 3: 701–708.

6. FreemanBE, HammarlundE, RauéH, SlifkaMK (2012) Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci 109: 9971–9976.

7. MarshallHD, PrinceAL, BergLJ, WelshRM (2010) IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J Immunol 185: 1419–1428.

8. RauéH, BeadlingC, HaunJ, SlifkaM (2013) Cytokine-mediated programmed proliferation of virus-specific CD8+ memory T cells. Immunity 38: 131–139.

9. RauéH, BrienJD, HammarlundE, SlifkaMK (2004) Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J Immunol 173: 6873–6881.

10. MeresseB, ChenZ, CiszewskiC, TretiakovaM, BhagatG, et al. (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357–366.

11. SacksD, Noben-TrauthN (2002) The immunology of susceptibility and resistance to leishmania major in mice. Nat Rev Immunol 2: 845–858.

12. KayeP, ScottP (2011) Leishmaniasis: Complexity at the host-pathogen interface. Nat Rev Micro 9: 604–615.

13. BelkaidY, Von StebutE, MendezS, LiraR, CalerE, et al. (2002) CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with leishmania major. J Immunol 168: 3992–4000.

14. UzonnaJE, JoyceKL, ScottP (2004) Low dose leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon γ–producing CD8+ T cells. J Exp Med 199: 1559–1566.

15. PearsonRD, SousaAdQ (1996) Clinical spectrum of leishmaniasis. Clin Infect Dis 22: 1–11.

16. MurrayHW, BermanJD, DaviesCR, SaraviaNG (2005) Advances in leishmaniasis. Lancet 366: 1561–1577.

17. LessaMM, LessaHA, CastroTWN, OliveiraA, ScheriferA, et al. (2007) Mucosal leishmaniasis: Epidemiological and clinical aspects. Braz J Otorhinolaryngol 73: 843–847.

18. BacellarO, FariaD, NascimentoM, CardosoTM, GollobKJ, et al. (2009) Interleukin 17 production among patients with american cutaneous leishmaniasis. J Infect Dis 200: 75–78.

19. BoaventuraVS, SantosCS, CardosoCR, de AndradeJ, Dos SantosWLC, et al. (2010) Human mucosal leishmaniasis: Neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur J Immunol 40: 2830–2836.

20. OliveiraF, BaficaA, RosatoAB, FavaliCBF, CostaJM, et al. (2011) Lesion size correlates with leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am J Trop Med Hyg 85: 70–73.

21. OliveiraCF, Manzoni-de-AlmeidaD, MelloPS, NataleCC, SantiagoHdC, et al. (2012) Characterization of chronic cutaneous lesions from TNF-receptor-1-deficient mice infected by Leishmania major. Clin Dev Immunol 1–12.

22. Gonzalez-LombanaC, GimbletC, BacellarO, OliveiraWW, PassosS, et al. (2013) IL-17 mediates immunopathology in the absence of IL-10 FollowingLeishmania majorInfection. PLoS Pathog 9: 1–13.

23. BrodskynCI, BarralA, BoaventuraV, CarvalhoE, Barral-NettoM (1997) Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J Immunol 159: 4467–4473.

24. FariaDR, SouzaPEA, DuraesFV, CarvalhoEM, GollobKJ, et al. (2009) Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol 31: 432–439.

25. SantosCdS, BoaventuraV, CardosoCR, TavaresN, LordeloMJ, et al. (2013) CD8+Granzyme B+ mediated tissue injury versus CD4+IFNg+ mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol 133: 1533–1540.

26. NoviasF, CarvalhoLP, GraffJW, BeitingDP, RuthelG, et al. (2013) Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog 9: e1003504.

27. ElyKH, CauleyLS, RobertsAD, BrennanJW, CookenhamT, et al. (2003) Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections. J Immunol 170: 1423–1429.

28. ButcherEC, PickerLJ (1996) Lymphocyte homing and homeostasis. Science 272: 60–67.

29. MasopustD, VezysV, UsherwoodEJ, CauleyLS, OlsonS, et al. (2004) Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol 172: 4875–4882.

30. VezysV, YatesA, CaseyKA, LanierG, AhmedR, et al. (2009) Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457: 196–199.

31. CornbergM, CluteSC, WatkinLB, SaccoccioFM, KimS, et al. (2010) CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections. Journal of Immunology 184: 2825–2838.

32. ChenAT, CornbergM, GrasS, GuillonneauC, RossjohnJ, et al. (2012) Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope. Plos Pathogens 8: e1002633.

33. BrehmMA, PintoAK, DanielsKA, SchneckJP, WelshRM, et al. (2002) T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 3: 627–634.

34. WlodarczykMF, KraftAR, ChenHD, KenneyLL, SelinLK (2013) Anti-IFN-gamma and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cells. Journal of Immunology 190: 2736–2746.

35. NieS, LinS, KimS, WelshRM, SelinLK (2010) Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoire. Am J Pathol 176: 2107–2112.

36. OverathP, HarbeckeD (1993) Course of leishmania infection in beta-2-microglobulin-deficient mice. Immunol Lett 37: 13–17.

37. WangZE, ReinerSL, HatamF, HeinzelFP, BouvierJ, et al. (1993) Targeted activation of CD8 cells and infection of beta-2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J Immunol 151: 2077–2086.

38. HuberM, TimmsE, MakT, RollinghoffM, LohoffM (1998) Effective and long-lasting immunity against the parasite leishmania major in CD8-deficient mice. Infect Immun 66: 3968–3970.

39. GrohV, WuJ, YeeC, SpiesT (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734–738.

40. JamiesonAM, DiefenbachA, McMahonCW, XiongN, CarlyleJR, et al. (2002) The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17: 19–29.

41. VernerisMR, KaramiM, BakerJ, JayaswalA, NegrinRS (2004) Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Blood 103: 3065–3072.

42. TietzeJK, WilkinsDEC, SckiselGD, BouchlakaMN, AldersonKL, et al. (2012) Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy. Blood 119: 3073–3083.

43. ChampsaurM, LanierLL (2010) Effect of NKG2D ligand expression on host immune responses. Immunol Rev 235: 267–285.

44. ZafirovaB, WensveenFM, GulinM, PolicB (2011) Regulation of immune cell function and differentiation by the NKG2D receptor. Cell Mol Life Sci 68: 3519–3529.

45. HermansIF, SilkJD, YangJ, PalmowskiMJ, GileadiU, et al. (2004) The VITAL assay: A versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J Immunol Methods 285: 25–40.

46. CerwenkaA, BaronJ, LanierL (2001) Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A 98: 11521–11526.

47. PeltolaVT, McCullersJA (2004) Respiratory viruses predisposing to bacterial infections: Role of neuraminidase. Pediatr Infect Dis J 23: S87–S96.

48. BeadlingC, SlifkaMK (2004) How do viral infections predispose patients to bacterial infections? Curr Opin Infect Dis 17: 185–191.

49. JonesWT, MennaJH, WennerstromDE (1983) Lethal synergism induced in mice by influenza type-a virus and type-ia group-B streptococci. Infect Immun 41: 618–623.

50. OkamotoS, KawabataS, NakagawaI, OkunoY, GotoT, et al. (2003) Influenza A virus-infected hosts boost an invasive type of streptococcus pyogenes infection in mice. J Virol 77: 4104–4112.

51. JamiesonAM, PasmanL, YuS, GamradtP, HomerRJ, et al. (2013) Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 340: 1230–1234.

52. StelekatiE, WherryE (2012) Chronic bystander infections and immunity to unrelated antigens. Cell Host Microbe 12: 458–469.

53. La FlammeA, ScottP, PearceE (2002) Schistosomiasis delays lesion resolution during leishmania major infection by impairing parasite killing by macrophages. Parasite Immunol 24: 339–345.

54. AndreaniG, LodgeR, RichardD, TremblayMJ (2012) Mechanisms of interaction between protozoan parasites and HIV. Curr Opin HIV AIDS 7: 276–282.

55. ToughDF, BorrowP, SprentJ (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947–1950.

56. EhlS, HombachJ, AicheleP, HengartnerH, ZinkernagelR (1997) Bystander activation of cytotoxic T cells: Studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J Exp Med 185: 1241–1251.

57. Murali-KrishnaK, AltmanJD, SureshM, SourdiveDJD, ZajacAJ, et al. (1998) Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8: 177–187.

58. MasopustD, Murali-KrishnaK, AhmedR (2007) Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: It is even bigger than we thought. J Virol 81: 2002–2011.

59. SelinLK, VargaSM, WongIC, WelshRM (1998) Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med 188: 1705–1715.

60. ChenHD, FraireAE, JorisI, BrehmMA, WelshRM, et al. (2001) Memory CD8(+)T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2: 1067–1076.

61. KimS, BrehmM, WelshR, SelinL (2002) Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J Immunol 169: 90–98.

62. ChenHD, FraireAE, JorisI, WelshRM, SelinLK (2003) Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 163: 1341–1355.

63. WelshRM, SelinLK, Szomolanyi-TsudaE (2004) Immunological memory to viral infections. Annu Rev Immunol 22: 711–743.

64. MathurinKS, MartensGW, KornfeldH, WelshRM (2009) CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. J Virol 83: 3528–3539.

65. KohlmeierJE, MillerSC, WoodlandDL (2007) Cutting edge: Antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways. J Immunol 178: 4721–4725.

66. KimS, CornbergM, WangXZ, ChenHD, SelinLK, et al. (2005) Private specificities of CD8 T cell responses control patterns of heterologous immunity. J Exp Med 201: 523–533.

67. VaradarajanN, JulgB, YamanakaYJ, ChenH, OgunniyiAO, et al. (2011) A high-throughput single-cell analysis of human CD8(+) T cell functions reveals discordance for cytokine secretion and cytolysis. J Clin Invest 121: 4322–4331.

68. RauéH, BeadlingC, HaunJ, SlifkaM (2013) Cytokine-mediated programmed proliferation of virus-specific CD8+ memory T cells. Immunity 38: 131–139.

69. Narni-MancinelliE, CampisiL, BassandD, CazarethJ, GounonP, et al. (2007) Memory CD8(+) T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes. J Exp Med 204: 2075–2087.

70. SchenkelJM, FraserKA, VezysV, MasopustD (2013) Sensing and alarm function of resident memory CD8+ T cells. Nat Immunol 14: 509–513.

71. WherryEJ, TeichgraberV, BeckerTC, MasopustD, KaechSM, et al. (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225–234.

72. OrtegaC, Fernandez-AS, CarrilloJM, RomeroP, MolinaIJ, et al. (2009) IL-17-producing CD8(+) T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J Leukoc Biol 86: 435–443.

73. ResPCM, PiskinG, de BoerOJ, van der LoosCM, TeelingP, et al. (2010) Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. Plos One 5: 1–11.

74. Da-CruzAM, Oliveira-NetoMP, BerthoAL, Mendes-AguiarCO, CoutinhoSG (2010) T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions. J Invest Dermatol 130: 1329–1336.

75. PircherH, BurkiK, LangR, HengartnerH, ZinkernagelRM (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559–561.

76. PrickettSP, GrayPM, ColpittsSL, ScottP, KayePM, et al. (2006) In vivo recognition of ovalbumin expressed by transgenic leishmania is determined by its subcellular localization. J Immunol 176: 4826–4833.

77. SpäthGF, BeverleySM (2001) A lipophosphoglycan-independent method for isolation of infective leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97–103.

78. ScottP, ArtisD, UzonnaJ, ZaphC (2004) The development of effector and memory T cells in cutaneous leishmaniasis: The implications for vaccine development. Immunol Rev 201: 318–338.